For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03866382
Contact name
Laura Morse Cucci
Clinical trials study type
Clinical trials trial status
IRB number
1857033
Principal investigator
Paul Celano, MD
Clinical trials study number
A031702
Phone
443-849-3122
Clinical trials title (full)
A031702: A phase II study of Ipilimumab, CabOzantinib, and NIvolumab in rare genitourinary Cancers